The Medicare Rx drug benefit could slash independent pharmacies' gross margins by 8%, sending them over the edge of unprofitability, according to industry analyst Arthur Flynn.
Pharmacy-Driven Vaccine Clinic to Reduce Number of Children Missing School | ASHP Midyear
Researchers presented the community-wide benefits of a collaborative pharmacy-driven vaccine clinic in an urban setting.
American Pharmacies: Powering the Profession Through Leadership
Drug Topics sat down with Laird Leavoy, President of American Pharmacies, to discuss the role leadership plays in the independent pharmacy industry.
Must-Have Tools for Pharmacy Innovation
Lisa Faast, PharmD, discusses how to use technology to innovate within the pharmacy.
How Centralized Fulfillment is Making Pharmacy More Efficient
Tom Utech, PharmD, CEO of iA, joined Drug Topics to discuss his company’s centralized pharmacy fulfillment solutions.
Role of Intranasal Fentanyl in Pain Management for Sickle Cell Disease | ASH 2024
Researchers evaluated the safety, feasibility, and effectiveness of intranasal fentanyl in an adult population.
Q&A: Statin, Nonstatin Combination Therapy to Treat Patients’ Cardiovascular Risk | ASHP Midyear
John Bucheit, PharmD, joined Drug Topics to discuss statins and nonstatins’ efficacy in treating cardiovascular disease.